per share is in play.
VMAT2 has been discounted out of the PPS ....... Elagolix is worth $10 PPS
Its a good thing that Abbvie has complete control over E's development programs
I agree...market has discounted VMAT to $0. Are they correct or not? That's the question.
Throw in the $2 in Cash and NBIX should be trading around $11/$12 PPS
I for one would not mind an Abbvie buy-out at around $17/$18 PPS.
lets just see what types of year End bonus and stock options management gives to themselves for their cowdung 2013 performance. These guys would blank-up a wetdream